Identification and Management of ILD in Systemic Sclerosis - Article
Identification and Management of ILD in Systemic Sclerosis - Article
From Lancet Rheumatology, this article reviews evidence-based consensus statements on guidance for the identification and medical management of systemic sclerosis-associated ILD.
What you’ll learn:
- The process used in developing evidence-based consensus statements on SSc-ILD management in relation to six domains: risk factors, screening, diagnosis and severity assessment, treatment initiation and options, disease progression, and treatment escalation
- The results of the expert panel regarding the six domains
- The algorithm developed for the identification and management of SSc-associated ILD
Related Resources
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Diagnosis of HP in Adults - Clinical Practice Guideline
Guidelines from the American Thoracic Society offering a systematic approach to diagnosing hypersensitivity pneumonitis (HP).
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Autoimmune Disease-Associated Interstitial Lung Disease - Slide Deck
Review autoimmune connective tissue disorders (CTDs) associated with ILD.
View Resource
Chronic Fibrosing ILD with Progressive Phenotype - HCP Resource
Hypersensitivity Pneumonitis - Slide Deck
Discover the characteristics, epidemiology, and pathogenesis of HP.
View Resource
